VRNA

Verona Pharma
VRNA

Overview Fund Activity

95 hedge funds and large institutions have $1.22B invested in Verona Pharma in 2023 Q1 according to their latest regulatory filings, with 22 funds opening new positions, 39 increasing their positions, 21 reducing their positions, and 13 closing their positions.

Holders
95
Holders Change
+7
Holders Change %
+7.95%
% of All Funds
1.52%
Holding in Top 10
14
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-12.5%
% of All Funds
0.22%
New
22
Increased
39
Reduced
21
Closed
13
Calls
$3.53M
Puts
$2.14M
Net Calls
+$1.39M
Net Calls Change
-$22.1M

Top Buyers

1
CG
1
Carlyle Group
District of Columbia
$49.3M
2
Fidelity Investments
2
Fidelity Investments
Massachusetts
$91.7M
3
WP
3
Woodline Partners
California
$35M
4
PBA
4
Paradigm Biocapital Advisors
New York
$19.3M
5
NIP
5
Nicholas Investment Partners
California
$18.9M

Top Sellers

1
PA
1
Perceptive Advisors
New York
$54.9M
2
Janus Henderson Group
2
Janus Henderson Group
United Kingdom
$4.48M
3
Point72 Asset Management
3
Point72 Asset Management
Connecticut
$0
4
O
4
OrbiMed
New York
$85.6M
5
MFS
5
Mirabella Financial Services
United Kingdom
$10.4M
Name Holding Trade Value Shares
Change 		Shares
Change %
CSS
101
Cubist Systematic Strategies
Connecticut
– -$504K -19,300 Closed
Truist Financial
102
Truist Financial
North Carolina
– -$303K -11,600 Closed
HSBC Holdings
103
HSBC Holdings
United Kingdom
– -$259K -10,041 Closed
RG
104
Rathbones Group
United Kingdom
– -$254K -9,709 Closed
XT
105
XTX Topco
Cayman Islands
– -$237K -9,081 Closed
NFC
106
Northeast Financial Consultants
Connecticut
– -$227K -8,700 Closed
Belvedere Trading
107
Belvedere Trading
Illinois
– -$227K -8,686 Closed
QT
108
Quantbot Technologies
New York
– -$22.5K -860 Closed
1 2 3 4
5